Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 7/20 | 1.00 |
| ▸ | SHBG | P04278 | 7/20 | 0.69 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.69 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | PGR | P06401 | 5/20 | 0.55 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.48 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.48 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25863609 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL1255845 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL29880093 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL5188310 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24102494 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL14342101 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24103284 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL5026430 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24103286 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL223290 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9393218-B2 | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers | EPINAMICS GMBH (DE) | 2016-07-19 | — | — | US | claimed |
| US-20150366800-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. | 2015-12-24 | — | — | US | claimed |
| EP-2667877-A2 | ANDROGEN COMPOSITION FOR TREATING AN OPHTHALMIC CONDITION | Allergan, Inc. (US) | 2013-12-04 | — | — | EP | claimed |
| CN-103415292-A | Androgen compositions for the treatment of ophthalmic conditions | ALLERGAN INC | 2013-11-27 | — | — | CN | claimed |
| WO-2012103186-A2 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. (US) | 2012-08-02 | — | — | WO | claimed |
| US-20120190661-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. | 2012-07-26 | — | — | US | claimed |
| EP-1962815-B1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | EPINAMICS GMBH (DE) | 2010-08-11 | — | — | EP | claimed |
| US-20100112027-A1 | Penis Enlargement | ADAMS KENNETH W | 2010-05-06 | — | — | US | claimed |
| CN-101346134-A | Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers | EPINAMICS GMBH (DE) | 2009-01-14 | — | — | CN | claimed |
| EP-1962815-A1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | Epinamics GmbH (DE) | 2008-09-03 | — | — | EP | claimed |
| US-20070248658-A1 | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers | EPINAMICS GMBH (DE) | 2007-10-25 | — | — | US | claimed |
| WO-2007077029-A1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | EPINAMICS GMBH (DE) | 2007-07-12 | — | — | WO | claimed |
| EP-1800671-A1 | Use of film-forming hair care polymers and pharmaceutical preparations and patches comprising such polymers | Bayer Schering Pharma Aktiengesellschaft (DE) | 2007-06-27 | — | — | EP | claimed |
| US-20060222708-A1 | Wafer comprising steroid hormones | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2006-10-05 | — | — | US | claimed |
| US-20050065159-A1 | Penis enlargement | Dr. Kenneth Adams Medicine Professional Corporation (CA) | 2005-03-24 | — | — | US | claimed |
| WO-2005011705-A1 | ENHANCEMENT OF ERECTILE FUNCTION | ADAMS KENNETH W (CA) | 2005-02-10 | — | — | WO | claimed |
| WO-2004011029-A2 | PHARMACEUTICAL COMPOSITIONS FOR PENIS ENLARGEMENT | ADAMS KENNETH W (CA) | 2004-02-05 | — | — | WO | claimed |
| EP-1343804-A1 | 14(15)-UNSATURATED 15- AND/OR 16- SUBSTITUTED ANDROGENS WITH MIXED ANDROGEN-PROGESTATIONAL PROFILE | Akzo Nobel N.V. (NL) | 2003-09-17 | — | — | EP | claimed |
| WO-2002048169-A1 | 14(15)-UNSATURATED 15- AND/OR 16- SUBSTITUTED ANDROGENS WITH MIXED ANDROGEN-PROGESTATIONAL PROFILE | AKZO NOBEL N.V. (NL) | 2002-06-20 | — | — | WO | claimed |
| US-11938105-B1 | Methods and compositions for the treatment of cancer cachexia | OHIO STATE INNOVATION FOUNDATION (US) | 2024-03-26 | — | — | US | disclosed |
| US-11560406-B2 | Anti-androgen peptides and uses thereof in cancer therapy | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2023-01-24 | — | — | US | disclosed |
| US-11529323-B2 | Methods and compositions for the treatment of cancer cachexia | OHIO STATE INNOVATION FOUNDATION (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220202829-A1 | NON-IRRITATING TESTOSTERONE EMULSIONS | ALLERGAN, INC. | 2022-06-30 | — | — | US | disclosed |
| US-20220000830-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2022-01-06 | — | — | US | disclosed |
| US-11090283-B2 | Solid forms of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2021-08-17 | — | — | US | disclosed |
| US-20210113588-A1 | NON-IRRITATING TESTOSTERONE EMULSIONS | ALLERGAN INC (US) | 2021-04-22 | — | — | US | disclosed |
| US-10905696-B2 | Androgen composition for treating an ophthalmic condition | ALLERGAN, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| EP-3388066-B1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN INC (US) | 2020-11-04 | — | — | EP | disclosed |
| US-10780098-B2 | Non-irritating testosterone emulsions | ALLERGAN, INC. (US) | 2020-09-22 | — | — | US | disclosed |
| US-20200289438-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA | OHIO STATE INNOVATION FOUNDATION | 2020-09-17 | — | — | US | disclosed |
| EP-3681493-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA | The Ohio State Innovation Foundation (US) | 2020-07-22 | — | — | EP | disclosed |
| EP-3147278-B1 | COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS | UNIV TENNESSEE RES FOUND (US) | 2020-02-12 | — | — | EP | disclosed |
| EP-2871177-B1 | Solid form of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | GTX INC (US) | 2019-07-17 | — | — | EP | disclosed |
| WO-2019055687-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA | OHIO STATE INNOVATION FOUNDATION (US) | 2019-03-21 | — | — | WO | disclosed |
| EP-3412685-A1 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | Cancer Research Technology Ltd. (GB) | 2018-12-12 | — | — | EP | disclosed |
| EP-3388066-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | Allergan, Inc. (US) | 2018-10-17 | — | — | EP | disclosed |
| US-20180271933-A1 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | CANCER RESEARCH TECH LTD (GB) | 2018-09-27 | — | — | US | disclosed |
| US-20180221388-A1 | NON-IRRITATING TESTOSTERONE EMULSIONS | ALLERGAN, INC. | 2018-08-09 | — | — | US | disclosed |
| EP-2139917-B1 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | CANCER RESEARCH TECH LTD (GB) | 2018-04-25 | — | — | EP | disclosed |
| US-9937188-B2 | Non-irritating testosterone emulsions | ALLERGAN, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-9919023-B2 | Anti-androgen peptides and uses thereof in cancer therapy | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2018-03-20 | — | — | US | disclosed |
| EP-2667877-B1 | ANDROGEN COMPOSITION FOR TREATING AN OPHTHALMIC CONDITION | ALLERGAN INC (US) | 2018-03-07 | — | — | EP | disclosed |
| EP-2205552-B1 | CRYSTALLINE POLYMORPH OF THE SELECTIVE ANDROGEN MODULATORS (R) OR (S)-N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-CYANOPHENOXY)-2-HYDROXY-2-METHYLPROPANAMIDE | GTX INC (US) | 2018-02-28 | — | — | EP | disclosed |
| US-20170266149-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | GTX, INC. (US) | 2017-09-21 | — | — | US | disclosed |
| EP-2289872-B1 | Medical uses of a selective androgen receptor modulator | UNIV TENNESSEE RES FOUND (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20170189412-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. | 2017-07-06 | — | — | US | disclosed |
| EP-3147278-A1 | COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS | University of Tennessee Research Foundation (US) | 2017-03-29 | — | — | EP | disclosed |
| CN-103251579-B | Substituted N-anilid and using method thereof | 田纳西大学研究基金会 | 2016-12-28 | — | — | CN | disclosed |
| US-9504646-B2 | Androgen composition for treating an opthalmic condition | ALLERGAN, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-9493403-B2 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2038252-B1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2016-11-02 | — | — | EP | disclosed |
| CN-103553966-B | The solid forms of SARM | GTX公司 | 2016-09-07 | — | — | CN | disclosed |
| EP-3056483-A1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2016-08-17 | — | — | EP | disclosed |
| US-9393218-B2 | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers | EPINAMICS GMBH (DE) | 2016-07-19 | — | — | US | disclosed |
| US-20160128969-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | GTX INC (US) | 2016-05-12 | — | — | US | disclosed |
| EP-2054049-B1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2016-04-13 | — | — | EP | disclosed |
| US-9278914-B2 | SARMs and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2016-03-08 | — | — | US | disclosed |
| US-20150366800-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. | 2015-12-24 | — | — | US | disclosed |
| CN-102976973-B | SARM and using method thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2015-10-21 | — | — | CN | disclosed |
| US-9150501-B2 | Solid forms of selective androgen receptor modulators | GTX, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-9119772-B2 | Androgen composition for treating an opthalmic condition | ALLERGAN, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20150202249-A1 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2015-07-23 | — | — | US | disclosed |
| EP-2871177-A1 | Solid form of (R) or (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | GTX, Inc. (US) | 2015-05-13 | — | — | EP | disclosed |
| US-9011913-B2 | Use of functionalized magnetic nanoparticles in cancer detection and treatment | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-04-21 | — | — | US | disclosed |
| EP-2266577-B1 | Multi-substituted selective androgen receptor modulators and methods of use therof | UNIV TENNESSEE RES FOUNDATION (US) | 2014-12-03 | — | — | EP | disclosed |
| CN-103073450-B | Solid forms of selective androgen receptor modulators | GTX CORP | 2014-12-03 | — | — | CN | disclosed |
| US-20140315872-A1 | NON-IRRITATING TESTOSTERONE EMULSIONS | ALLERGAN, INC. (US) | 2014-10-23 | — | — | US | disclosed |
| US-8846756-B2 | Substituted acylanilides and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140221479-A1 | SARMS AND METHOD OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140163115-A1 | Migraine Treatments using the Bone Homeostasis Drug Cinacalcet | ZAMOYSKI MARK (US) | 2014-06-12 | — | — | US | disclosed |
| US-8669286-B2 | SARMs and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-03-11 | — | — | US | disclosed |
| US-20140051764-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2014-02-20 | — | — | US | disclosed |
| CN-103553966-A | Solid forms of selective androgen receptor modulators | GTX INC | 2014-02-05 | — | — | CN | disclosed |
| US-20140005263-A1 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-01-02 | — | — | US | disclosed |
| CN-101516840-B | Substituted acylanilides and methods of use thereof | UNIV TENNESSEE RES FOUNDATION | 2013-12-25 | — | — | CN | disclosed |
| US-20130324602-A1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2013-12-05 | — | — | US | disclosed |
| EP-2667877-A2 | ANDROGEN COMPOSITION FOR TREATING AN OPHTHALMIC CONDITION | Allergan, Inc. (US) | 2013-12-04 | — | — | EP | disclosed |
| CN-103415292-A | Androgen compositions for the treatment of ophthalmic conditions | ALLERGAN INC | 2013-11-27 | — | — | CN | disclosed |
| US-8563606-B2 | Solid forms of selective androgen receptor modulators | GTX, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| CN-103251579-A | Substituted acylanilides and methods of use thereof | UNIV TENNESSEE RES FOUNDATION | 2013-08-21 | — | — | CN | disclosed |
| CN-101855198-B | Solid forms of selective androgen receptor modulators | UNIV TENNESSEE RES FOUNDATION | 2013-07-10 | — | — | CN | disclosed |
| CN-101528214-B | Substituted anilides and methods of use thereof | UNIV TENNESSEE RES FOUNDATION | 2013-06-05 | — | — | CN | disclosed |
| US-8445534-B2 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-05-21 | — | — | US | disclosed |
| US-20130122085-A1 | PHARMACEUTICAL COMPOSITIONS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | GTX, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2013067170-A1 | PHARMACEUTICAL COMPOSITIONS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | GTX, INC. (US) | 2013-05-10 | — | — | WO | disclosed |
| CN-103073450-A | Solid forms of selective androgen receptor modulators | UNIV TENNESSEE RES FOUNDATION | 2013-05-01 | — | — | CN | disclosed |
| EP-1592658-B1 | Large-scale synthesis of selective androgen receptor modulators | UNIV TENNESSEE RES FOUNDATION (US) | 2013-04-24 | — | — | EP | disclosed |
| US-8426465-B2 | Substituted acylanilides and methods of use thereof | UNIVERSITY OF TENNESSE RESEARCH FOUNDATION (US) | 2013-04-23 | — | — | US | disclosed |
| CN-102976973-A | Selective androgen receptor modulator and method for using thereof | UNIV TENNESSEE RES FOUNDATION | 2013-03-20 | — | — | CN | disclosed |
| US-20130058946-A1 | Seizure and Migraine Treatments using Denosumab | ZAMOYSKI MARK JOHN (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130035387-A1 | SARMS AND METHOD OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-02-07 | — | — | US | disclosed |
| CN-102905526-A | SARM and methods of use thereof | UNIV TENNESSEE RES FOUNDATION | 2013-01-30 | — | — | CN | disclosed |
| US-8309603-B2 | SARMs and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2012-11-13 | — | — | US | disclosed |
| US-20120214876-A1 | Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet | ZAMOYSKI MARK JOHN (US) | 2012-08-23 | — | — | US | disclosed |
| WO-2012103186-A2 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. (US) | 2012-08-02 | — | — | WO | disclosed |
| US-20120190661-A1 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | ALLERGAN, INC. | 2012-07-26 | — | — | US | disclosed |
| US-8197858-B2 | Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate | ZAMOYSKI MARK JOHN (US) | 2012-06-12 | — | — | US | disclosed |
| US-20120136052-A1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2012-05-31 | — | — | US | disclosed |
| EP-2457892-A1 | Large-scale synthesis of selective androgen receptor modulators | University of Tennessee Research Foundation (US) | 2012-05-30 | — | — | EP | disclosed |
| CN-1726185-B | Halogeno-selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION | 2012-05-23 | — | — | CN | disclosed |
| CN-101284795-B | Non-steroidal male hormone receptor regulating agent and medical uses thereof | SHANGHAI INST MATERIA MEDICA | 2012-04-25 | — | — | CN | disclosed |
| EP-1753417-B1 | A SELECTIVE ANDROGEN RECEPTOR MODULATOR AND MEDICAL USES THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2012-04-04 | — | — | EP | disclosed |
| US-8110562-B2 | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-8088828-B2 | Treating benign prostate hyperplasia with SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2012-01-03 | — | — | US | disclosed |
| US-8080682-B2 | Substituted acylanilides and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-12-20 | — | — | US | disclosed |
| EP-1487458-B1 | MULTI-SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2011-11-16 | — | — | EP | disclosed |
| US-20110263703-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-10-27 | — | — | US | disclosed |
| WO-2011132449-A1 | ELECTRIC INCINERATOR TOILET, AND INCINERATION CONTROL METHOD FOR ELECTRIC INCINERATOR TOILET | 株式会社ディラック (JP) | 2011-10-27 | — | — | WO | disclosed |
| US-8003689-B2 | Metabolites of selective androgen receptor modulators and methods of use thereof | GTX, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| EP-1480634-B1 | Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia | UNIV TENNESSEE RES FOUNDATION (US) | 2011-08-03 | — | — | EP | disclosed |
| US-7977386-B2 | Solid forms of selective androgen receptor modulators | UNIVERSTIY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-07-12 | — | — | US | disclosed |
| US-7968603-B2 | Solid forms of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-06-28 | — | — | US | disclosed |
| US-7968721-B2 | Coupling a N-phenyl-1-bromo-2-substituted propamide with a substituted hydroxy-, amino-, phosphino-, or seleno- benzene compound; crystallization and filtration; industrial scale, high purity; non-steroidal agonists | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-06-28 | — | — | US | disclosed |
| CN-1700923-B | Multi-substituted selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP | 2011-06-15 | — | — | CN | disclosed |
| US-20110082212-A1 | MULTI-SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-04-07 | — | — | US | disclosed |
| EP-2305636-A1 | Selective androgen receptor modulators and methods of use thereof | University of Tennessee Research Foundation (US) | 2011-04-06 | — | — | EP | disclosed |
| US-7919647-B2 | N-(3-substituted-4-cyano)phenyl-2-hydroxy-2-methyl-3-(4-cyano)phenoxy propamides; spermatogenesis inhibitors, hormone replacement therapy, anticarcinogenic, antiproliferative agents for prostate cancer, apoptotic agents; bone and muscle disorders | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-04-05 | — | — | US | disclosed |
| US-20110077221-A1 | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2011-03-31 | — | — | US | disclosed |
| EP-2289872-A2 | Selective androgen receptor modulators and medical uses thereof | University of Tennessee Research Foundation (US) | 2011-03-02 | — | — | EP | disclosed |
| US-20110044911-A1 | Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-02-24 | — | — | US | disclosed |
| EP-2284149-A1 | Selective androgen receptor modulators and methods of use thereof | University of Tennessee Research Foundation (US) | 2011-02-16 | — | — | EP | disclosed |
| EP-2266577-A1 | Multi-substitued selective androgen receptor modulators and methods of use therof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-12-29 | — | — | EP | disclosed |
| CN-1826313-B | Large-scale synthesis of selective androgen receptor modulators | GTX INC | 2010-12-08 | — | — | CN | disclosed |
| US-20100280107-A1 | TREATING BENIGN PROSTATE HYPERPLASIA WITH SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2010-11-04 | — | — | US | disclosed |
| CN-101855198-A | Solid forms of selective androgen receptor modulators | UNIV TENNESSEE RES FOUNDATION | 2010-10-06 | — | — | CN | disclosed |
| US-20100249228-A1 | SARMS AND METHOD OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2010-09-30 | — | — | US | disclosed |
| US-7803970-B2 | Multi-substitued selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-09-28 | — | — | US | disclosed |
| EP-2222636-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF | Ligand Pharmaceuticals Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| US-7776921-B2 | Treating benign prostate hyperplasia with SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-20100203168-A1 | Bone microenvironment modulated seizure treatments | ZAMOYSKI MARK JOHN | 2010-08-12 | — | — | US | disclosed |
| WO-2009082437-A9 | SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2010-08-12 | — | — | WO | disclosed |
| EP-1962815-B1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | EPINAMICS GMBH (DE) | 2010-08-11 | — | — | EP | disclosed |
| US-7772433-B2 | SARMS and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-08-10 | — | — | US | disclosed |
| US-20100189776-A1 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | CANCER RESEARCH TECHNOLOGY LTD (GB) | 2010-07-29 | — | — | US | disclosed |
| US-7759520-B2 | Synthesis of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-07-20 | — | — | US | disclosed |
| EP-2205552-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | University of Tennessee Research Foundation (US) | 2010-07-14 | — | — | EP | disclosed |
| US-7741371-B2 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-06-22 | — | — | US | disclosed |
| US-20100137430-A1 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2010-06-03 | — | — | US | disclosed |
| CN-1736371-B | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP | 2010-05-12 | — | — | CN | disclosed |
| US-20100112027-A1 | Penis Enlargement | ADAMS KENNETH W | 2010-05-06 | — | — | US | disclosed |
| US-7705182-B2 | preventing and/or treating dry eye conditions; cancer; hormone-related conditions; oral bioavailability, lack of cross-reactivity with other steroid receptors, and long biological half-lives | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-04-27 | — | — | US | disclosed |
| CN-101688248-A | Androgen-dependent gene fusion comprising the 1f aromatase promoter and a reporter gene | BAYER SCHERING PHARMA AG | 2010-03-31 | — | — | CN | disclosed |
| US-7671091-B2 | Penis enlargement | Dr. Kenneth Adams Medicine Professional Corporation (CA) | 2010-03-02 | — | — | US | disclosed |
| US-20100022641-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2010-01-28 | — | — | US | disclosed |
| US-7645898-B2 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-01-12 | — | — | US | disclosed |
| US-20100004326-A1 | METABOLITES OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | ONCTERNAL THERAPEUTICS, INC | 2010-01-07 | — | — | US | disclosed |
| EP-2139917-A2 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | Cancer Research Technology Ltd (GB) | 2010-01-06 | — | — | EP | disclosed |
| WO-2009155481-A1 | METABOLITES OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | GTX, INC. (US) | 2009-12-23 | — | — | WO | disclosed |
| US-7622503-B2 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090264534-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-10-22 | — | — | US | disclosed |
| WO-2009123735-A1 | USE OF FUNCTIONALIZED MAGNETIC NANOPARTICLES IN CANCER DETECTION AND TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-10-08 | — | — | WO | disclosed |
| CN-100537520-C | N-bridged selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2009-09-09 | — | — | CN | disclosed |
| CN-101528214-A | Substituted anilides and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2009-09-09 | — | — | CN | disclosed |
| CN-101516835-A | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof | OSURF OHIO STATE UNIVERSITY RE (US) | 2009-08-26 | — | — | CN | disclosed |
| CN-101516840-A | Substituted acylanilides and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2009-08-26 | — | — | CN | disclosed |
| WO-2009082437-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2009-07-02 | — | — | WO | disclosed |
| US-20090156614-A1 | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof | OHIO STATE UNIVERSITY RESEARCH FOUNDATION | 2009-06-18 | — | — | US | disclosed |
| EP-2054049-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2009-05-06 | — | — | EP | disclosed |
| EP-1558565-B1 | HALOGENATED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2009-04-29 | — | — | EP | disclosed |
| US-7518013-B2 | Selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2009-04-14 | — | — | US | disclosed |
| US-20090088480-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-04-02 | — | — | US | disclosed |
| EP-2040709-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS, ANALOGS AND DERIVATIVES THEREOF AND USES THEREOF | OSURF (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-2041077-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS, ANALOGS AND DERIVATIVES THEREOF AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-2038252-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2009-03-25 | — | — | EP | disclosed |
| WO-2009036206-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2009-03-19 | — | — | WO | disclosed |
| EP-1491524-B1 | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2009-02-18 | — | — | EP | disclosed |
| CN-101346134-A | Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers | EPINAMICS GMBH (DE) | 2009-01-14 | — | — | CN | disclosed |
| CN-101333174-A | N-bridged selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2008-12-31 | — | — | CN | disclosed |
| US-20080319009-A1 | Methylene-bridged selective androgen receptor modulators and methods of use thereof | DALTON JAMES T | 2008-12-25 | — | — | US | disclosed |
| EP-1562594-A4 | METHYLENE-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2008-12-17 | — | — | EP | disclosed |
| CN-101284795-A | Non-steroidal male hormone receptor regulating agent and medical uses thereof | SHANGHAI INST MATERIA MEDICA (CN) | 2008-10-15 | — | — | CN | disclosed |
| WO-2008113770-A2 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY | CANCER RESEARCH TECHNOLOGY LTD (GB) | 2008-09-25 | — | — | WO | disclosed |
| EP-1962815-A1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | Epinamics GmbH (DE) | 2008-09-03 | — | — | EP | disclosed |
| US-20080193380-A1 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | DALTON JAMES T | 2008-08-14 | — | — | US | disclosed |
| US-20080076829-A1 | Substituted acylanilides and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2008-03-27 | — | — | US | disclosed |
| US-20080076828-A1 | Substituted acylanilides and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2008-03-27 | — | — | US | disclosed |
| US-7344700-B2 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2008-03-18 | — | — | US | disclosed |
| US-20080057068-A1 | SARMS and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2008-03-06 | — | — | US | disclosed |
| WO-2008024456-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-02-28 | — | — | WO | disclosed |
| WO-2008011073-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS, ANALOGS AND DERIVATIVES THEREOF AND USES THEREOF | OSURF (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008011072-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS, ANALOGS AND DERIVATIVES THEREOF AND USES THEREOF | OSURF (OHIO STATE UNIVERSITY RESEARCH FOUNDATION) (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008008433-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-1480634-A4 | TREATING BENIGN PROSTATE HYPERPLASIA WITH SARMS | GTX INC (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070265290-A1 | Heterocyclic selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-11-15 | — | — | US | disclosed |
| WO-2007126988-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-11-08 | — | — | WO | disclosed |
| CN-101062023-A | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-10-31 | — | — | CN | disclosed |
| US-20070248658-A1 | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers | EPINAMICS GMBH (DE) | 2007-10-25 | — | — | US | disclosed |
| US-7253210-B2 | Methylene-bridged selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-08-07 | — | — | US | disclosed |
| US-20070173546-A1 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-07-26 | — | — | US | disclosed |
| WO-2007081696-A2 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | GTX, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
| CN-100999481-A | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-07-18 | — | — | CN | disclosed |
| WO-2007077029-A1 | USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS | EPINAMICS GMBH (DE) | 2007-07-12 | — | — | WO | disclosed |
| EP-1800671-A1 | Use of film-forming hair care polymers and pharmaceutical preparations and patches comprising such polymers | Bayer Schering Pharma Aktiengesellschaft (DE) | 2007-06-27 | — | — | EP | disclosed |
| US-20070123563-A1 | Selective androgen receptor modulators and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-05-31 | — | — | US | disclosed |
| CN-1972682-A | Metabolites of selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-05-30 | — | — | CN | disclosed |
| CN-1964712-A | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-05-16 | — | — | CN | disclosed |
| US-7214693-B2 | Heterocyclic selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-05-08 | — | — | US | disclosed |
| US-7205437-B2 | Selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-04-17 | — | — | US | disclosed |
| EP-1764357-A1 | Selective androgen receptor modulators and methods of use thereof | University of Tennessee Research Foundation (US) | 2007-03-21 | — | — | EP | disclosed |
| US-20060287282-A1 | Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof | GTX, INC | 2006-12-21 | — | — | US | disclosed |
| US-20060287547-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-12-21 | — | — | US | disclosed |
| US-20060276540-A1 | Selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-12-07 | — | — | US | disclosed |
| US-20060276539-A1 | Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS | GTX, INC | 2006-12-07 | — | — | US | disclosed |
| EP-1592658-A4 | LARGE-SCALE SYNTHESIS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | GTX INC (US) | 2006-11-29 | — | — | EP | disclosed |
| US-20060258628-A1 | Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof | GTX INC | 2006-11-16 | — | — | US | disclosed |
| EP-1401801-B1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES CORP (US) | 2006-11-02 | — | — | EP | disclosed |
| US-20060241180-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSE RESEARCH FOUNDATION | 2006-10-26 | — | — | US | disclosed |
| US-20060229362-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-10-12 | — | — | US | disclosed |
| EP-1705174-A1 | Selective androgen receptor modulators and methods of use thereof | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2006-09-27 | — | — | EP | disclosed |
| EP-1487783-A4 | IRREVERSIBLE SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2006-09-27 | — | — | EP | disclosed |
| EP-1534663-A4 | N-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2006-08-30 | — | — | EP | disclosed |
| CN-1826313-A | Large-scale synthesis of selective androgen receptor modulators | GTX INC (US) | 2006-08-30 | — | — | CN | disclosed |
| US-20060183931-A1 | Multi-substituted selective androgen receptor modulators and methods of use thereof | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION | 2006-08-17 | — | — | US | disclosed |
| EP-1487458-A4 | MULTI-SUBSTITUED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2006-07-26 | — | — | EP | disclosed |
| CN-1771031-A | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS [ | GTX INC (US) | 2006-05-10 | — | — | CN | disclosed |
| EP-1558565-A4 | HALOGENATED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2006-04-19 | — | — | EP | disclosed |
| US-7026500-B2 | Halogenated selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2006-04-11 | — | — | US | disclosed |
| US-7022870-B2 | N-bridged selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2006-04-04 | — | — | US | disclosed |
| EP-1594490-A4 | TREATING ANDROGEN DEFICIENCY IN FEMALE (ADIF)-ASSOCIATED CONDITIONS WITH SARMS | GTX INC (US) | 2006-03-22 | — | — | EP | disclosed |
| CN-1736981-A | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2006-02-22 | — | — | CN | disclosed |
| CN-1736371-A | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2006-02-22 | — | — | CN | disclosed |
| US-20060035965-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-16 | — | — | US | disclosed |
| US-20060035966-A1 | Irreversible selective androgen receptor modulators and methods of use thereof | DALTON JAMES T | 2006-02-16 | — | — | US | disclosed |
| US-6998500-B2 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2006-02-14 | — | — | US | disclosed |
| US-6995284-B2 | Synthesis of selective androgen receptor modulators | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2006-02-07 | — | — | US | disclosed |
| CN-1726193-A | Heterocycle SARM and using method thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1726020-A | Treatment of androgen decline in aging Male (ADAM) -associated diseases with SARM | GTX INC (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1726185-A | Halogeno-selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1726019-A | Treating obesity with selective androgen receptor modulators | GTX INC (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1726034-A | The SARM of methylene-bridged and application process thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2006-01-25 | — | — | CN | disclosed |
| US-20060009529-A1 | Synthesis of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-01-12 | — | — | US | disclosed |
| US-20060004042-A1 | Formulations comprising selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-01-05 | — | — | US | disclosed |
| CN-1230418-C | Selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2005-12-07 | — | — | CN | disclosed |
| CN-1700923-A | Multi-substituted selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2005-11-23 | — | — | CN | disclosed |
| EP-1487780-A4 | HALOACETAMIDE AND AZIDE SUBSTITUTED COMPOUNDS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2005-11-16 | — | — | EP | disclosed |
| EP-1594490-A2 | TREATING ANDROGEN DEFICIENCY IN FEMALE (ADIF)-ASSOCIATED CONDITIONS WITH SARMS | GTX, Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| EP-1592658-A2 | LARGE-SCALE SYNTHESIS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | GTX Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| CN-1694864-A | N-bridged selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2005-11-09 | — | — | CN | disclosed |
| US-20050209320-A1 | Anti-cancer compounds and methods of use thereof | GTX, INC. | 2005-09-22 | — | — | US | disclosed |
| EP-1562906-A2 | HETEROCYCLIC SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2005-08-17 | — | — | EP | disclosed |
| EP-1562594-A2 | METHYLENE-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2005-08-17 | — | — | EP | disclosed |
| EP-1558233-A2 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | GTX, Inc. (US) | 2005-08-03 | — | — | EP | disclosed |
| EP-1558565-A2 | HALOGENATED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-08-03 | — | — | EP | disclosed |
| CN-1646479-A | Irreversible selective androgen receptor modulators and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2005-07-27 | — | — | CN | disclosed |
| CN-1639110-A | Haloacetamide and azide substituted compounds and methods of use thereof | UNIV TENNESSEE RES CORP (US) | 2005-07-13 | — | — | CN | disclosed |
| EP-1534663-A1 | N-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005037206-A2 | ANTI-CANCER COMPOUNDS AND METHODS OF USE THEREOF | GTX, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| US-20050080054-A1 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-04-14 | — | — | US | disclosed |
| US-20050065159-A1 | Penis enlargement | Dr. Kenneth Adams Medicine Professional Corporation (CA) | 2005-03-24 | — | — | US | disclosed |
| US-20050038110-A1 | N-phenyl-2-hydroxy-2-methyl-3-(p-cyano)phenoxypropamides; spermatogenesis inhibitors, hormone replacement therapy, anticarcinogenic agents for prostate cancer, apoptotic agents, dry eye | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-02-17 | — | — | US | disclosed |
| US-20050032750-A1 | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS | GTX INC | 2005-02-10 | — | — | US | disclosed |
| US-20050033074-A1 | Multi-substitued selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-02-10 | — | — | US | disclosed |
| WO-2005011705-A1 | ENHANCEMENT OF ERECTILE FUNCTION | ADAMS KENNETH W (CA) | 2005-02-10 | — | — | WO | disclosed |
| US-6838484-B2 | Formulations comprising selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-01-04 | — | — | US | disclosed |
| US-20040265916-A1 | Method for detecting selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-12-30 | — | — | US | disclosed |
| US-20040260092-A1 | Large-scale synthesis of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-12-23 | — | — | US | disclosed |
| US-20040260108-A1 | Metabolites of selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-12-23 | — | — | US | disclosed |
| EP-1487783-A2 | IRREVERSIBLE SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | University of Tennessee Research Foundation (US) | 2004-12-22 | — | — | EP | disclosed |
| EP-1487780-A1 | HALOACETAMIDE AND AZIDE SUBSTITUTED COMPOUNDS AND METHODS OF USE THEREOF | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2004-12-22 | — | — | EP | disclosed |
| EP-1487458-A2 | MULTI-SUBSTITUED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2004-12-22 | — | — | EP | disclosed |
| EP-1480634-A2 | TREATING BENIGN PROSTATE HYPERPLASIA WITH SARMS | GTX, Inc. (US) | 2004-12-01 | — | — | EP | disclosed |
| US-20040224979-A1 | Treating obesity with selective androgen receptor modulators | TENNESSEE RESEARCH FOUNDATION, UNIVERSITY OF | 2004-11-11 | — | — | US | disclosed |
| EP-1470151-A1 | PROCESS FOR THE PREPARATION OF 7-ALPHA-METHYLSTEROIDS | Akzo Nobel N.V. (NL) | 2004-10-27 | — | — | EP | disclosed |
| US-20040197928-A1 | Method for detecting selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-10-07 | — | — | US | disclosed |
| US-20040167103-A1 | Haloacetamide and azide substituted compounds and methods of use thereof | TENNESSEE, UNIVERSITY OF RESEARCH FOUNDATION | 2004-08-26 | — | — | US | disclosed |
| EP-1401801-A4 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIV TENNESSEE RES CORP (US) | 2004-08-18 | — | — | EP | disclosed |
| WO-2004064747-A2 | TREATING ANDROGEN DEFICIENCY IN FEMALE (ADIF)-ASSOCIATED CONDITIONS WITH SARMS | GTX INC. (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040147489-A1 | Haloacetamide and azide substituted compounds and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH CORPORATION, THE | 2004-07-29 | — | — | US | disclosed |
| US-20040147550-A1 | Methylene-bridged selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-07-29 | — | — | US | disclosed |
| WO-2004062612-A2 | LARGE-SCALE SYNTHESIS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | GTX INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| US-20040138244-A1 | Heterocyclic selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-07-15 | — | — | US | disclosed |
| US-20040087810-A1 | Irreversible selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2004-05-06 | — | — | US | disclosed |
| WO-2004035737-A2 | HETEROCYCLIC SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004035739-A2 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | GTX, INC. (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004035736-A2 | HALOGENATED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004035738-A2 | METHYLENE-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-04-29 | — | — | WO | disclosed |
| US-20040067979-A1 | N-bridged selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-04-08 | — | — | US | disclosed |
| EP-1401801-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20040052727-A1 | Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-03-18 | — | — | US | disclosed |
| US-20040053897-A1 | Treating benign prostate hyperplasia with SARMS | TENNESSEE RESEARCH FOUNDATION, UNIVERSITY OF | 2004-03-18 | — | — | US | disclosed |
| US-20040029913-A1 | Halogenated selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-02-12 | — | — | US | disclosed |
| WO-2004011029-A2 | PHARMACEUTICAL COMPOSITIONS FOR PENIS ENLARGEMENT | ADAMS KENNETH W (CA) | 2004-02-05 | — | — | WO | disclosed |
| CN-1471508-A | Selective androgen receptor modulators and methods of use thereof | ��ѧ�о��� | 2004-01-28 | — | — | CN | disclosed |
| US-20040014975-A1 | Synthesis of selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2004-01-22 | — | — | US | disclosed |
| WO-2003106401-A1 | N-BRIDGED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2003-12-24 | — | — | WO | disclosed |
| US-20030232792-A1 | Selective androgen receptor modulators and methods of use thereof | TENNESSEE RESEARCH CORPORATION, THE UNIVERSITY OF | 2003-12-18 | — | — | US | disclosed |
| US-20030225040-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2003-12-04 | — | — | US | disclosed |
| US-20030199514-A1 | Methods for improving efficacy of treatment with growth hormone secretagogues | FRYBURG DAVID A (US) | 2003-10-23 | — | — | US | disclosed |
| EP-1353938-A1 | ANDROGENIC 7-SUBSTITUTED 11-HALOGENATED STEROIDS | Schering Aktiengesellschaft (DE) | 2003-10-22 | — | — | EP | disclosed |
| WO-2003074449-A2 | MULTI-SUBSTITUED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003074471-A1 | HALOACETAMIDE AND AZIDE SUBSTITUTED COMPOUNDS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003074450-A2 | RADIOLABELED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND THEIR USE IN PROSTATE CANCER IMAGING AND THERAPY | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003074473-A2 | IRREVERSIBLE SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2003-09-12 | — | — | WO | disclosed |
| US-20030162761-A1 | Formulations comprising selective androgen receptor modulators | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2003-08-28 | — | — | US | disclosed |
| WO-2003065992-A2 | TREATING BENIGN PROSTATE HYPERPLASIA WITH SARMS | GTX, INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003059931-A1 | PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS | AKZO NOBEL N.V. (NL) | 2003-07-24 | — | — | WO | disclosed |
| US-6569896-B2 | Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION | 2003-05-27 | — | — | US | disclosed |
| US-20030022868-A1 | Selective androgen receptor modulators and methods of use thereof | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION | 2003-01-30 | — | — | US | disclosed |
| US-6492554-B2 | SUBSTITUTED ALPHA-HYDROXYISOBUTYRANILIDES; SUPPRESSING SPERMATOGENESIS; HORMONE THERAPY | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION | 2002-12-10 | — | — | US | disclosed |
| US-20020173495-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2002-11-21 | — | — | US | disclosed |
| WO-2002059139-A1 | ANDROGENIC 7-SUBSTITUTED 11-HALOGEN STEROIDS | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-08-01 | — | — | WO | disclosed |
| US-20020099036-A1 | Selective androgen receptor modulators and methods of use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-07-25 | — | — | US | disclosed |
| US-20020099096-A1 | Selective androgen receptor modulators and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH CORPORATION, THE | 2002-07-25 | — | — | US | disclosed |
| WO-2002016310-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-1128810-A1 | DRUG DELIVERY DEVICE, ESPECIALLY FOR THE DELIVERY OF ANDROGENS | LEIRAS OY (FI) | 2001-09-05 | — | — | EP | disclosed |
| US-6160011-A | Non-steroidal agonist compounds and their use in male hormone therapy | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000028967-A1 | DRUG DELIVERY DEVICE, ESPECIALLY FOR THE DELIVERY OF ANDROGENS | LEIRAS OY (FI) | 2000-05-25 | — | — | WO | disclosed |
| WO-1998053826-A1 | NON-STEROIDAL AGONIST COMPOUNDS AND THEIR USE IN MALE HORMONE THERAPY | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1998-12-03 | — | — | WO | disclosed |
| WO-1998053826-A1 | NON-STEROIDAL AGONIST COMPOUNDS AND THEIR USE IN MALE HORMONE THERAPY | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1998-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136052-A1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | CPT1B, MTPN, MUSK | AR 388/4885SHBG 1917/4885SERPINA6 4113/4885 |
| US-20030022868-A1 | Selective androgen receptor modulators and methods of use thereof | AR, SHBG, GNRHR | AR 1/4885SHBG 2/4885SERPINA6 553/4885 |
| US-20160128969-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1233/4885 |
| US-20140221479-A1 | SARMS AND METHOD OF USE THEREOF | CPT1B, FABP4, SARM1 | AR 1933/4885SHBG 282/4885SERPINA6 953/4885 |
| US-20030232792-A1 | Selective androgen receptor modulators and methods of use thereof | CYP19A1, AR, SHBG | AR 2/4885SHBG 3/4885SERPINA6 961/4885 |
| US-20060035965-A1 | Selective androgen receptor modulators and methods of use thereof | AR, ESRRA, SHBG | AR 1/4885SHBG 3/4885SERPINA6 556/4885 |
| US-20130035387-A1 | SARMS AND METHOD OF USE THEREOF | CPT1B, FABP4, SARM1 | AR 1933/4885SHBG 282/4885SERPINA6 953/4885 |
| US-20040067979-A1 | N-bridged selective androgen receptor modulators and methods of use thereof | CYP19A1, SHBG, FSHR | AR 4/4885SHBG 2/4885SERPINA6 1317/4885 |
| US-20030225040-A1 | Selective androgen receptor modulators and methods of use thereof | CYP19A1, SHBG, FSHR | AR 4/4885SHBG 2/4885SERPINA6 719/4885 |
| US-20030162761-A1 | Formulations comprising selective androgen receptor modulators | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 1004/4885 |
| US-20100004326-A1 | METABOLITES OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | AR, SHBG, GPR119 | AR 1/4885SHBG 2/4885SERPINA6 1118/4885 |
| US-20090264534-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 943/4885 |
| US-20110263703-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1204/4885 |
| US-20020173495-A1 | Selective androgen receptor modulators and methods of use thereof | AR, SHBG, FSHR | AR 1/4885SHBG 2/4885SERPINA6 667/4885 |
| US-20040224979-A1 | Treating obesity with selective androgen receptor modulators | AR, ADIPOR2, ADIPOR1 | AR 1/4885SHBG 13/4885SERPINA6 500/4885 |
| US-20110077221-A1 | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof | AR, ESRRA, SHBG | AR 1/4885SHBG 3/4885SERPINA6 512/4885 |
| US-20070173546-A1 | Selective androgen receptor modulators and method of use thereof | AR, SHBG, ESRRA | AR 1/4885SHBG 2/4885SERPINA6 567/4885 |
| US-20080076829-A1 | Substituted acylanilides and methods of use thereof | CPT1B, MTPN, MUSK | AR 388/4885SHBG 1917/4885SERPINA6 4113/4885 |
| US-20100137430-A1 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | AR, SHBG, SARM1 | AR 1/4885SHBG 2/4885SERPINA6 2337/4885 |
| US-20080193380-A1 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | AR, SHBG, GNRHR | AR 1/4885SHBG 2/4885SERPINA6 349/4885 |
| US-20060258628-A1 | Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof | CYP19A1, CYP17A1, SRD5A1 | AR 5/4885SHBG 6/4885SERPINA6 1485/4885 |
| US-20040260108-A1 | Metabolites of selective androgen receptor modulators and methods of use thereof | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 1567/4885 |
| US-20220000830-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1233/4885 |
| US-20040260092-A1 | Large-scale synthesis of selective androgen receptor modulators | FSHR, AR, CYP19A1 | AR 2/4885SHBG 4/4885SERPINA6 1884/4885 |
| US-20130122085-A1 | PHARMACEUTICAL COMPOSITIONS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | AR, SHBG, INSR | AR 1/4885SHBG 2/4885SERPINA6 228/4885 |
| US-20170266149-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1233/4885 |
| US-20020099096-A1 | Selective androgen receptor modulators and methods of use thereof | AR, GNRHR, SHBG | AR 1/4885SHBG 3/4885SERPINA6 249/4885 |
| US-20030199514-A1 | Methods for improving efficacy of treatment with growth hormone secretagogues | GHSR, CYP21A2, GHRHR | AR 88/4885SHBG 6/4885SERPINA6 316/4885 |
| US-20060229362-A1 | Selective androgen receptor modulators and methods of use thereof | AR, NR5A1, FSHR | AR 1/4885SHBG 6/4885SERPINA6 461/4885 |
| US-20110044911-A1 | Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment | FOLR1, MKI67, CD47 | AR 1704/4885SHBG 2070/4885SERPINA6 3529/4885 |
| US-20080057068-A1 | SARMS and method of use thereof | SARM1, CKMT1A; CKMT1B, TNNI3 | AR 577/4885SHBG 87/4885SERPINA6 2132/4885 |
| US-20140005263-A1 | TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS | AR, SHBG, SARM1 | AR 1/4885SHBG 2/4885SERPINA6 2337/4885 |
| US-20060276540-A1 | Selective androgen receptor modulators | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 844/4885 |
| US-20050080054-A1 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMS | AR, CYP17A1, CYP19A1 | AR 1/4885SHBG 5/4885SERPINA6 3201/4885 |
| US-20140051764-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1233/4885 |
| US-20100022641-A1 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | AR 1/4885SHBG 6/4885SERPINA6 1233/4885 |
| US-20040053897-A1 | Treating benign prostate hyperplasia with SARMS | AR, SRD5A1, SRD5A2 | AR 1/4885SHBG 38/4885SERPINA6 2861/4885 |
| US-20130324602-A1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | CPT1B, MTPN, MUSK | AR 388/4885SHBG 1917/4885SERPINA6 4113/4885 |
| US-20070265290-A1 | Heterocyclic selective androgen receptor modulators and methods of use thereof | CYP19A1, FSHR, AR | AR 3/4885SHBG 4/4885SERPINA6 1747/4885 |
| US-20200289438-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA | HDAC5, HDAC1, HDAC7 | AR 11/4885SHBG 38/4885SERPINA6 517/4885 |
| US-20070123563-A1 | Selective androgen receptor modulators and method of use thereof | AR, SHBG, ESRRA | AR 1/4885SHBG 2/4885SERPINA6 567/4885 |
| US-20020099036-A1 | Selective androgen receptor modulators and methods of use thereof | AR, SHBG, FSHR | AR 1/4885SHBG 2/4885SERPINA6 250/4885 |
| US-20040147489-A1 | Haloacetamide and azide substituted compounds and methods of use thereof | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 2240/4885 |
| US-20110082212-A1 | MULTI-SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | SHBG, FSHR, AR | AR 3/4885SHBG 1/4885SERPINA6 684/4885 |
| US-20050032750-A1 | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS | AR, SHBG, CYP19A1 | AR 1/4885SHBG 2/4885SERPINA6 2714/4885 |
| US-11938105-B1 | Methods and compositions for the treatment of cancer cachexia | HDAC5, HDAC1, HDAC7 | AR 11/4885SHBG 38/4885SERPINA6 517/4885 |
| US-20060009529-A1 | Synthesis of selective androgen receptor modulators | AR, CYP19A1, SHBG | AR 1/4885SHBG 3/4885SERPINA6 1137/4885 |
| US-20100249228-A1 | SARMS AND METHOD OF USE THEREOF | CPT1B, FABP4, SARM1 | AR 1933/4885SHBG 282/4885SERPINA6 953/4885 |
| US-20060035966-A1 | Irreversible selective androgen receptor modulators and methods of use thereof | AR, SHBG, FSHR | AR 1/4885SHBG 2/4885SERPINA6 1460/4885 |
| US-20080076828-A1 | Substituted acylanilides and methods of use thereof | CPT1B, MTPN, MUSK | AR 502/4885SHBG 1706/4885SERPINA6 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.